Studies with preclinical glioma resection models revealed that the expression level of Ki-67, the marker for cell proliferation, is statistically higher in the specimens of recurrent gliomas; on the other hand, CD31, the initiative marker for blood vessels, is statistically lower [193]. Here, PECAM1 is linked to glioma.